Markus Schwaiger, MD, Receives SNMMI Georg Charles de Hevesy Nuclear Pioneer Award
Markus Schwaiger, MD, was named this year’s recipient of the Georg Charles de Hevesy Nuclear Pioneer Award at SNMMI's Annual Meeting.
Category: Nuclear Medicine
Nuclear Medicine
Latest
Nuclear Medicine
Latest
PET/CT Effective in Evaluating and Monitoring Post-COVID-19 Lung Disease
PET/CT has been proven successful in evaluating lung inflammation and monitoring treatment in patients with post-COVID-19 lung disease.
Nuclear Medicine
Latest
MITA Joins Over 70 Organizations Requesting Congressional Leaders Hold Hearings on FIND Act
MITA and other groups sent a letter to members of Congress requesting they hold hearings to consider the FIND Act of 2021 (H.R. 4479).
PSMA PET Validates EAU Classification System to Determine Risk of Prostate Cancer Recurrence
New research has confirmed the accuracy of the novel European Association of Urology (EAU) risk classification system that groups prostate cancer patients based on their risk of recurrence.
Read More
PET/CT Artificial Intelligence Model Ideal for Predicting Risk of Future Heart Attack
By combining information from two advanced imaging techniques with clinical data, physicians can improve their prediction of heart attacks, according to research published in The Journal of Nuclear Medicine
Read More
SNMMI Publishes Appropriate Use Criteria for Prostate-Specific Membrane Antigen PET Imaging
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) and peer medical groups have issued appropriate use criteria for prostate-specific membrane antigen PET imaging.
Read More
PET Scans Help Guide Drug to Treat Orthopedic Implant Bacterial Infections
Johns Hopkins Medicine researchers have shown that PET scans can be used to “see” the movement of the drug rifampin in a living body, so that it can better treat bacterial infections attacking orthopedic implant-assisted bone.
Read More
RSNA, RadSite Team Up to Promote Pilot Program for FDG PET/CT Biomarker Profile
The Radiological Society of North America (RSNA) is teaming up with RadSite, an accreditation organization for advanced diagnostic imaging, to pilot the RSNA Quantitative Imaging Biomarkers Alliance Profile for fluorodeoxyglucose (FDG) PET/CT imaging.
Read More